Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates
Cary R. Boyd-Shiwarski, Rebecca T. Beacham, Jared A. Lashway, Katherine E. Querry, Shawn E. Griffiths, Daniel J. Shiwarski, Sophia A. Knoell, Nga H. Nguyen, Lubika J. Nkashama, Melissa N. Valladares, Anagha Bandaru, Allison L. Marciszyn, Jonathan Franks, Mara Sullivan, Simon C. Watkins, Aylin R. Rodan, Chou-Long Huang, Sean D. Stocker, Ossama B. Kashlan, Arohan R. Subramanya
Cary R. Boyd-Shiwarski, Rebecca T. Beacham, Jared A. Lashway, Katherine E. Querry, Shawn E. Griffiths, Daniel J. Shiwarski, Sophia A. Knoell, Nga H. Nguyen, Lubika J. Nkashama, Melissa N. Valladares, Anagha Bandaru, Allison L. Marciszyn, Jonathan Franks, Mara Sullivan, Simon C. Watkins, Aylin R. Rodan, Chou-Long Huang, Sean D. Stocker, Ossama B. Kashlan, Arohan R. Subramanya
View: Text | PDF
Research Article Cell biology Nephrology

Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates

  • Text
  • PDF
Abstract

To maintain potassium homeostasis, the kidney’s distal convoluted tubule (DCT) evolved to convert small changes in blood [K+] into robust effects on salt reabsorption. This process requires NaCl cotransporter (NCC) activation by the with-no-lysine (WNK) kinases. During hypokalemia, the kidney-specific WNK1 isoform (KS-WNK1) scaffolds the DCT-expressed WNK signaling pathway within biomolecular condensates of unknown function termed WNK bodies. Here, we show that KS-WNK1 amplified kidney tubule reactivity to blood [K+], in part via WNK bodies. In genetically modified mice, targeted condensate disruption trapped the WNK pathway, causing renal salt wasting that was more pronounced in females. In humans, WNK bodies accumulated as plasma potassium fell below 4.0 mmol/L, suggesting that the human DCT experiences the stress of potassium deficiency, even when [K+] is in the low-to-normal range. These data identify WNK bodies as kinase signal amplifiers that mediate tubular [K+] responsiveness, nephron sexual dimorphism, and BP salt sensitivity. Our results illustrate how biomolecular condensate specialization can optimize a mammalian physiologic stress response that impacts human health.

Authors

Cary R. Boyd-Shiwarski, Rebecca T. Beacham, Jared A. Lashway, Katherine E. Querry, Shawn E. Griffiths, Daniel J. Shiwarski, Sophia A. Knoell, Nga H. Nguyen, Lubika J. Nkashama, Melissa N. Valladares, Anagha Bandaru, Allison L. Marciszyn, Jonathan Franks, Mara Sullivan, Simon C. Watkins, Aylin R. Rodan, Chou-Long Huang, Sean D. Stocker, Ossama B. Kashlan, Arohan R. Subramanya

×

Figure 8

Potassium-restricted KS-WNK1–KO mice are thiazide insensitive.

Options: View larger image (or click on image) Download as PowerPoint
Potassium-restricted KS-WNK1–KO mice are thiazide insensitive.
(A) Schem...
(A) Schematic of the BP telemetry experiment. Female WT (n = 4) and KS-WNK1–KO mice (n = 6) were subjected to either low K+ or control diets for 10 days, followed by supplementation with 1% normal saline in drinking water for 3 days and then hydrochlorothiazide (HCTZ) treatment. (B) KS-WNK1 expression had no significant effect on mean arterial pressure (MAP) in K+-restricted or control diet–fed mice. Saline supplementation increased MAP in K+-restricted mice. Genotype had no significant effect determined by 2-way ANOVA with post hoc Šídák’s test. Each data point represents either daytime or nighttime MAP averaged over 6 hours. (C) Thiazide challenge. Mice were fed low K+ or control diet for 10 days and then 1% saline in their drinking water for 3 days. Daytime MAP was measured for a 6-hour window, starting on day 14 (24 hours before HCTZ injection) and on day 15 (1 hour after HCTZ injection) (25 mg/kg IP). WT mice on low K+ diet had a significant decrease in MAP with HCTZ administration, compared with KS-WNK1–KO mice. *P ≤ 0.05, 2-way ANOVA with post hoc Šídák’s test. (D) Schematic of the metabolic cage experiment. Diuretic challenge was performed in both female and male WT and KS-WNK1–KO mice. After 10 days of control or low K+ diet, mice were injected with HCTZ (25 mg/kg IP), and urine was collected for 6 hours. (E) Urine volume and (F) urine Na+V were greater in WT mice compared with those in KO mice. (G) On the low K+ diet, urine K+ was too low to detect a significant difference. (H) There was a trend for HCTZ to blunt Cl– excretion in KS-WNK1–KO mice on low K+ diet, without reaching significance. Results are shown as mean ± SEM; n = 12 mice per genotype and diet. Two-way ANOVA with Šídák’s post test; *P ≤ 0.05, **P ≤ 0.01. See also Supplemental Tables 2 and 3.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts